 Shaodong Dai
Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Antigen, T-Cell | 9 | 2022 | 718 | 2.130 |
Why?
| | CD4-Positive T-Lymphocytes | 12 | 2022 | 1091 | 1.760 |
Why?
| | Nickel | 4 | 2021 | 62 | 1.750 |
Why?
| | Hypersensitivity | 7 | 2021 | 257 | 1.630 |
Why?
| | Autoantigens | 7 | 2022 | 430 | 1.170 |
Why?
| | Prosthesis Failure | 2 | 2021 | 123 | 1.160 |
Why?
| | Peptides | 11 | 2022 | 985 | 1.110 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 5 | 2022 | 336 | 1.080 |
Why?
| | Histocompatibility Antigens Class II | 5 | 2022 | 367 | 1.040 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2022 | 3715 | 0.930 |
Why?
| | Berylliosis | 5 | 2016 | 186 | 0.920 |
Why?
| | Models, Molecular | 24 | 2021 | 1570 | 0.880 |
Why?
| | Haptens | 2 | 2021 | 22 | 0.810 |
Why?
| | T-Lymphocytes | 7 | 2021 | 1996 | 0.750 |
Why?
| | Peptide Fragments | 4 | 2020 | 706 | 0.740 |
Why?
| | Transcriptome | 6 | 2022 | 971 | 0.740 |
Why?
| | Insulin | 4 | 2022 | 2409 | 0.720 |
Why?
| | CD8-Positive T-Lymphocytes | 3 | 2022 | 900 | 0.720 |
Why?
| | Joint Prosthesis | 1 | 2021 | 21 | 0.710 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2022 | 195 | 0.690 |
Why?
| | Alzheimer Disease | 3 | 2022 | 560 | 0.690 |
Why?
| | HLA-DQ Antigens | 2 | 2019 | 181 | 0.680 |
Why?
| | Protein Conformation | 14 | 2021 | 934 | 0.680 |
Why?
| | Mice, Inbred NOD | 7 | 2022 | 601 | 0.680 |
Why?
| | Bryostatins | 1 | 2020 | 1 | 0.670 |
Why?
| | Epitopes | 3 | 2017 | 479 | 0.660 |
Why?
| | Alternative Splicing | 1 | 2022 | 229 | 0.660 |
Why?
| | Drugs, Chinese Herbal | 2 | 2017 | 21 | 0.640 |
Why?
| | Data Mining | 2 | 2017 | 116 | 0.590 |
Why?
| | Arthroplasty, Replacement | 2 | 2020 | 45 | 0.560 |
Why?
| | Echinococcus granulosus | 1 | 2017 | 1 | 0.550 |
Why?
| | Organogold Compounds | 1 | 2017 | 5 | 0.550 |
Why?
| | NADH, NADPH Oxidoreductases | 1 | 2017 | 18 | 0.550 |
Why?
| | Protein Processing, Post-Translational | 4 | 2018 | 465 | 0.540 |
Why?
| | Multienzyme Complexes | 1 | 2017 | 68 | 0.540 |
Why?
| | Machine Learning | 1 | 2022 | 493 | 0.510 |
Why?
| | Plants, Medicinal | 1 | 2016 | 22 | 0.510 |
Why?
| | Epitopes, T-Lymphocyte | 4 | 2021 | 181 | 0.490 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2016 | 191 | 0.460 |
Why?
| | Drug Discovery | 1 | 2015 | 142 | 0.450 |
Why?
| | Amino Acid Sequence | 10 | 2019 | 2139 | 0.430 |
Why?
| | HLA-DR Antigens | 2 | 2020 | 228 | 0.430 |
Why?
| | HLA-DP beta-Chains | 5 | 2016 | 86 | 0.420 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2015 | 220 | 0.420 |
Why?
| | Protein Binding | 14 | 2020 | 2224 | 0.420 |
Why?
| | HLA-DP Antigens | 2 | 2010 | 33 | 0.410 |
Why?
| | Co-Repressor Proteins | 2 | 2023 | 18 | 0.390 |
Why?
| | Animals | 29 | 2024 | 36940 | 0.390 |
Why?
| | Beryllium | 4 | 2016 | 153 | 0.390 |
Why?
| | Arthropod Proteins | 1 | 2012 | 4 | 0.380 |
Why?
| | Aprotinin | 1 | 2012 | 9 | 0.380 |
Why?
| | Salivary Proteins and Peptides | 1 | 2012 | 14 | 0.380 |
Why?
| | Ixodes | 1 | 2012 | 14 | 0.370 |
Why?
| | Ticks | 1 | 2012 | 25 | 0.370 |
Why?
| | Metals | 1 | 2013 | 136 | 0.370 |
Why?
| | Crystallography, X-Ray | 11 | 2018 | 476 | 0.370 |
Why?
| | Histocompatibility Antigen H-2D | 2 | 2022 | 21 | 0.370 |
Why?
| | Dermatitis, Allergic Contact | 1 | 2012 | 73 | 0.370 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1809 | 0.360 |
Why?
| | Mice | 20 | 2022 | 17787 | 0.360 |
Why?
| | Databases, Factual | 1 | 2016 | 1357 | 0.330 |
Why?
| | Evolution, Molecular | 2 | 2012 | 493 | 0.330 |
Why?
| | Alleles | 3 | 2010 | 891 | 0.320 |
Why?
| | Humans | 40 | 2025 | 137585 | 0.320 |
Why?
| | Binding Sites | 6 | 2017 | 1303 | 0.310 |
Why?
| | Ferredoxins | 1 | 2007 | 10 | 0.280 |
Why?
| | Protein Structure, Tertiary | 8 | 2012 | 861 | 0.270 |
Why?
| | Oxidoreductases | 1 | 2007 | 92 | 0.260 |
Why?
| | Iron-Sulfur Proteins | 1 | 2007 | 46 | 0.260 |
Why?
| | Medicine, Chinese Traditional | 2 | 2017 | 6 | 0.260 |
Why?
| | Molecular Sequence Data | 8 | 2015 | 2900 | 0.260 |
Why?
| | Mutation | 6 | 2022 | 3958 | 0.250 |
Why?
| | Single-Domain Antibodies | 1 | 2025 | 15 | 0.240 |
Why?
| | Molecular Conformation | 3 | 2022 | 145 | 0.230 |
Why?
| | HIV Infections | 1 | 2020 | 2836 | 0.230 |
Why?
| | Antigens | 2 | 2020 | 357 | 0.230 |
Why?
| | Hybridomas | 3 | 2021 | 237 | 0.230 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 62 | 0.220 |
Why?
| | Genetic Predisposition to Disease | 5 | 2019 | 2426 | 0.220 |
Why?
| | Hydrogen Bonding | 2 | 2017 | 163 | 0.210 |
Why?
| | DNA-Binding Proteins | 4 | 2023 | 1502 | 0.210 |
Why?
| | Amino Acids | 2 | 2022 | 497 | 0.200 |
Why?
| | HLA-DR Serological Subtypes | 2 | 2013 | 4 | 0.200 |
Why?
| | Oxygenases | 1 | 2002 | 12 | 0.200 |
Why?
| | Polychlorinated Biphenyls | 1 | 2002 | 12 | 0.200 |
Why?
| | Disulfides | 2 | 2022 | 107 | 0.200 |
Why?
| | Receptors, Steroid | 1 | 2023 | 50 | 0.200 |
Why?
| | Nucleic Acids | 1 | 2024 | 71 | 0.200 |
Why?
| | Dioxygenases | 1 | 2002 | 26 | 0.200 |
Why?
| | Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2022 | 8 | 0.200 |
Why?
| | Calcitonin Gene-Related Peptide | 1 | 2022 | 38 | 0.200 |
Why?
| | Hepatitis B virus | 1 | 2022 | 40 | 0.190 |
Why?
| | AlkB Enzymes | 1 | 2022 | 1 | 0.190 |
Why?
| | Hirudo medicinalis | 1 | 2022 | 1 | 0.190 |
Why?
| | Leeches | 1 | 2022 | 3 | 0.190 |
Why?
| | Islet Amyloid Polypeptide | 1 | 2022 | 47 | 0.190 |
Why?
| | Germ Cells | 1 | 2022 | 64 | 0.190 |
Why?
| | Rift Valley fever virus | 1 | 2021 | 2 | 0.190 |
Why?
| | Support Vector Machine | 1 | 2022 | 38 | 0.190 |
Why?
| | Biomarkers, Tumor | 2 | 2021 | 1276 | 0.190 |
Why?
| | Saccharomyces cerevisiae | 2 | 2025 | 557 | 0.190 |
Why?
| | Histones | 3 | 2018 | 636 | 0.190 |
Why?
| | Aspergillus nidulans | 1 | 2021 | 6 | 0.180 |
Why?
| | Bacterial Proteins | 4 | 2018 | 879 | 0.180 |
Why?
| | Transglutaminases | 1 | 2022 | 156 | 0.180 |
Why?
| | Molecular Docking Simulation | 2 | 2019 | 114 | 0.180 |
Why?
| | VDJ Exons | 1 | 2021 | 2 | 0.180 |
Why?
| | Protein Structure, Secondary | 3 | 2012 | 374 | 0.180 |
Why?
| | Lymphoma, Mantle-Cell | 1 | 2021 | 21 | 0.180 |
Why?
| | Structure-Activity Relationship | 2 | 2016 | 570 | 0.180 |
Why?
| | Glycoproteins | 2 | 2014 | 342 | 0.170 |
Why?
| | Early Growth Response Protein 2 | 1 | 2020 | 10 | 0.170 |
Why?
| | Sequence Alignment | 3 | 2012 | 343 | 0.170 |
Why?
| | GATA2 Transcription Factor | 1 | 2020 | 15 | 0.170 |
Why?
| | Core Binding Factor Alpha 2 Subunit | 1 | 2020 | 31 | 0.170 |
Why?
| | HLA-DRB4 Chains | 1 | 2020 | 6 | 0.170 |
Why?
| | STAT5 Transcription Factor | 1 | 2020 | 57 | 0.170 |
Why?
| | Environmental Pollutants | 1 | 2002 | 159 | 0.170 |
Why?
| | Muromegalovirus | 1 | 2020 | 23 | 0.170 |
Why?
| | Transcription Factor AP-1 | 1 | 2020 | 92 | 0.170 |
Why?
| | Neoplasms, Experimental | 1 | 2021 | 176 | 0.170 |
Why?
| | Response Elements | 1 | 2020 | 91 | 0.170 |
Why?
| | NFATC Transcription Factors | 1 | 2020 | 95 | 0.170 |
Why?
| | Toxoplasmosis | 1 | 2020 | 40 | 0.160 |
Why?
| | Toxoplasma | 1 | 2020 | 42 | 0.160 |
Why?
| | Polyethylene Glycols | 1 | 2025 | 641 | 0.160 |
Why?
| | Amino Acid Motifs | 4 | 2021 | 225 | 0.160 |
Why?
| | Trace Elements | 1 | 2020 | 51 | 0.160 |
Why?
| | Interleukin-13 | 1 | 2020 | 149 | 0.160 |
Why?
| | Cytochrome P-450 CYP3A Inducers | 1 | 2019 | 6 | 0.160 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 98 | 0.160 |
Why?
| | Major Histocompatibility Complex | 3 | 2013 | 227 | 0.160 |
Why?
| | Virus Latency | 1 | 2020 | 80 | 0.160 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2021 | 123 | 0.160 |
Why?
| | Mast Cells | 1 | 2020 | 147 | 0.160 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2021 | 175 | 0.160 |
Why?
| | Sarcoidosis | 1 | 2021 | 159 | 0.160 |
Why?
| | Hodgkin Disease | 1 | 2021 | 138 | 0.160 |
Why?
| | Protein Interaction Maps | 1 | 2019 | 48 | 0.150 |
Why?
| | Herpesviridae Infections | 1 | 2020 | 147 | 0.150 |
Why?
| | Purines | 1 | 2020 | 176 | 0.150 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2018 | 27 | 0.150 |
Why?
| | Antigens, Neoplasm | 1 | 2021 | 319 | 0.150 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 2018 | 57 | 0.150 |
Why?
| | Protein Kinase C | 1 | 2020 | 261 | 0.150 |
Why?
| | Chronic Disease | 3 | 2020 | 1793 | 0.150 |
Why?
| | Lysosomes | 1 | 2019 | 141 | 0.150 |
Why?
| | Antigen Presentation | 3 | 2020 | 218 | 0.150 |
Why?
| | Models, Genetic | 1 | 2021 | 600 | 0.140 |
Why?
| | Enzyme Inhibitors | 2 | 2017 | 840 | 0.140 |
Why?
| | Single-Cell Analysis | 1 | 2021 | 313 | 0.140 |
Why?
| | Histone Demethylases | 1 | 2018 | 32 | 0.140 |
Why?
| | Thymus Gland | 1 | 2019 | 312 | 0.140 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 617 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2021 | 812 | 0.140 |
Why?
| | Autoimmunity | 2 | 2014 | 908 | 0.140 |
Why?
| | Helminth Proteins | 1 | 2017 | 24 | 0.140 |
Why?
| | Glutaredoxins | 1 | 2017 | 13 | 0.140 |
Why?
| | Cytidine Deaminase | 1 | 2017 | 61 | 0.140 |
Why?
| | Protein Domains | 1 | 2019 | 289 | 0.140 |
Why?
| | Insecta | 1 | 2017 | 67 | 0.130 |
Why?
| | Up-Regulation | 1 | 2020 | 843 | 0.130 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2019 | 188 | 0.130 |
Why?
| | Immune Tolerance | 1 | 2019 | 363 | 0.130 |
Why?
| | Pancreas | 1 | 2019 | 329 | 0.130 |
Why?
| | Lymphocyte Activation | 3 | 2010 | 1142 | 0.130 |
Why?
| | Kinetics | 3 | 2012 | 1670 | 0.130 |
Why?
| | Pyrimidines | 1 | 2020 | 470 | 0.130 |
Why?
| | Antiviral Agents | 1 | 2022 | 744 | 0.130 |
Why?
| | Bipolar Disorder | 1 | 2019 | 263 | 0.130 |
Why?
| | Protein Folding | 1 | 2017 | 280 | 0.120 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2017 | 93 | 0.120 |
Why?
| | Cysteine | 1 | 2017 | 204 | 0.120 |
Why?
| | Catalytic Domain | 3 | 2021 | 207 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2020 | 528 | 0.120 |
Why?
| | Chromogranin A | 1 | 2015 | 42 | 0.120 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2015 | 184 | 0.120 |
Why?
| | Transcription Factors | 3 | 2017 | 1719 | 0.120 |
Why?
| | Cancer Vaccines | 2 | 2021 | 172 | 0.110 |
Why?
| | Cell Line, Tumor | 2 | 2021 | 3412 | 0.110 |
Why?
| | Conserved Sequence | 2 | 2021 | 239 | 0.110 |
Why?
| | Azides | 1 | 2014 | 46 | 0.110 |
Why?
| | Lamivudine | 1 | 2014 | 63 | 0.110 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2014 | 84 | 0.110 |
Why?
| | Transcription, Genetic | 1 | 2020 | 1457 | 0.110 |
Why?
| | HIV-1 | 1 | 2020 | 864 | 0.110 |
Why?
| | Gene Expression Profiling | 2 | 2021 | 1774 | 0.110 |
Why?
| | DNA | 4 | 2024 | 1459 | 0.110 |
Why?
| | Drug Resistance, Viral | 1 | 2014 | 116 | 0.100 |
Why?
| | Gene Expression Regulation | 1 | 2023 | 2607 | 0.100 |
Why?
| | Signal Transduction | 4 | 2020 | 5079 | 0.100 |
Why?
| | Deoxycytidine | 1 | 2014 | 179 | 0.100 |
Why?
| | HIV | 1 | 2014 | 234 | 0.100 |
Why?
| | Computer Simulation | 2 | 2016 | 978 | 0.100 |
Why?
| | Antibodies, Monoclonal | 1 | 2020 | 1430 | 0.100 |
Why?
| | Computational Biology | 1 | 2017 | 644 | 0.090 |
Why?
| | Phosphoproteins | 1 | 2014 | 338 | 0.090 |
Why?
| | Cross Reactions | 2 | 2011 | 133 | 0.090 |
Why?
| | Aging | 1 | 2022 | 1864 | 0.090 |
Why?
| | Blood | 1 | 2012 | 107 | 0.090 |
Why?
| | Multigene Family | 1 | 2012 | 198 | 0.090 |
Why?
| | H-2 Antigens | 1 | 2011 | 115 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2021 | 1272 | 0.090 |
Why?
| | Parkinson Disease | 1 | 2017 | 493 | 0.090 |
Why?
| | Mice, Transgenic | 4 | 2021 | 2167 | 0.090 |
Why?
| | Ligands | 4 | 2020 | 664 | 0.090 |
Why?
| | Lysine | 1 | 2012 | 294 | 0.080 |
Why?
| | Fusion Proteins, bcr-abl | 1 | 2010 | 69 | 0.080 |
Why?
| | Flow Cytometry | 3 | 2025 | 1178 | 0.080 |
Why?
| | RNA | 2 | 2022 | 921 | 0.080 |
Why?
| | Aged | 2 | 2022 | 23961 | 0.080 |
Why?
| | Lipids | 1 | 2014 | 672 | 0.080 |
Why?
| | Oxidation-Reduction | 2 | 2018 | 1060 | 0.080 |
Why?
| | Allergens | 1 | 2013 | 409 | 0.080 |
Why?
| | bcl-X Protein | 2 | 2006 | 43 | 0.080 |
Why?
| | bcl-2-Associated X Protein | 2 | 2006 | 56 | 0.080 |
Why?
| | Protein Interaction Domains and Motifs | 2 | 2021 | 150 | 0.080 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2010 | 122 | 0.080 |
Why?
| | Immunoglobulin G | 2 | 2025 | 893 | 0.080 |
Why?
| | Carrier Proteins | 2 | 2023 | 771 | 0.080 |
Why?
| | Membrane Proteins | 3 | 2006 | 1164 | 0.080 |
Why?
| | Immunity, Innate | 1 | 2014 | 828 | 0.070 |
Why?
| | Stroke | 1 | 2017 | 1120 | 0.070 |
Why?
| | Glutamic Acid | 1 | 2010 | 246 | 0.070 |
Why?
| | Protein Structure, Quaternary | 1 | 2008 | 128 | 0.070 |
Why?
| | Anti-HIV Agents | 1 | 2014 | 778 | 0.070 |
Why?
| | Surface Plasmon Resonance | 1 | 2008 | 87 | 0.070 |
Why?
| | Spinacia oleracea | 1 | 2007 | 9 | 0.070 |
Why?
| | Synechocystis | 1 | 2007 | 3 | 0.070 |
Why?
| | Oxidoreductases, N-Demethylating | 1 | 2007 | 16 | 0.070 |
Why?
| | Thioredoxins | 1 | 2007 | 30 | 0.070 |
Why?
| | Histocompatibility Antigens | 1 | 2008 | 105 | 0.070 |
Why?
| | Electron Transport | 1 | 2007 | 115 | 0.070 |
Why?
| | Burkholderia | 1 | 2006 | 12 | 0.070 |
Why?
| | Methylation | 3 | 2018 | 230 | 0.070 |
Why?
| | Plant Proteins | 1 | 2007 | 113 | 0.060 |
Why?
| | Cohort Studies | 1 | 2017 | 5742 | 0.060 |
Why?
| | Hydrolases | 1 | 2006 | 48 | 0.060 |
Why?
| | Female | 5 | 2021 | 73304 | 0.060 |
Why?
| | Feeding Behavior | 1 | 2012 | 654 | 0.060 |
Why?
| | Phenols | 1 | 2006 | 99 | 0.060 |
Why?
| | Cells, Cultured | 3 | 2020 | 4193 | 0.060 |
Why?
| | Complementarity Determining Regions | 3 | 2011 | 51 | 0.060 |
Why?
| | Cell Line | 3 | 2020 | 2847 | 0.060 |
Why?
| | Ferric Compounds | 1 | 2025 | 56 | 0.060 |
Why?
| | Iron | 1 | 2007 | 313 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 2017 | 2253 | 0.050 |
Why?
| | Demethylation | 1 | 2024 | 3 | 0.050 |
Why?
| | Recombinant Proteins | 1 | 2007 | 1353 | 0.050 |
Why?
| | Liposomes | 1 | 2025 | 223 | 0.050 |
Why?
| | Meiosis | 1 | 2024 | 82 | 0.050 |
Why?
| | Case-Control Studies | 2 | 2021 | 3556 | 0.050 |
Why?
| | Lung Diseases | 1 | 2010 | 767 | 0.050 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2021 | 1396 | 0.050 |
Why?
| | Biodegradation, Environmental | 1 | 2002 | 84 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2003 | 164 | 0.050 |
Why?
| | Cytochrome c Group | 1 | 2002 | 43 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 233 | 0.050 |
Why?
| | Macromolecular Substances | 1 | 2002 | 229 | 0.050 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 665 | 0.050 |
Why?
| | Mammals | 1 | 2024 | 283 | 0.050 |
Why?
| | Chemical Phenomena | 1 | 2021 | 83 | 0.050 |
Why?
| | Catalysis | 1 | 2002 | 307 | 0.050 |
Why?
| | Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| | Antigens, Fungal | 1 | 2021 | 28 | 0.050 |
Why?
| | Spodoptera | 1 | 2021 | 40 | 0.050 |
Why?
| | Interferon Type I | 1 | 2022 | 140 | 0.050 |
Why?
| | HLA-DR3 Antigen | 1 | 2021 | 80 | 0.040 |
Why?
| | Base Sequence | 2 | 2015 | 2181 | 0.040 |
Why?
| | Models, Chemical | 1 | 2002 | 263 | 0.040 |
Why?
| | Interleukin-2 | 2 | 2015 | 455 | 0.040 |
Why?
| | Fungal Proteins | 1 | 2021 | 123 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2671 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2023 | 378 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2021 | 121 | 0.040 |
Why?
| | Ubiquitin | 1 | 2021 | 70 | 0.040 |
Why?
| | Cryoelectron Microscopy | 1 | 2021 | 190 | 0.040 |
Why?
| | Antigens, Protozoan | 1 | 2020 | 24 | 0.040 |
Why?
| | T-Cell Antigen Receptor Specificity | 1 | 2020 | 50 | 0.040 |
Why?
| | Crystallization | 2 | 2015 | 143 | 0.040 |
Why?
| | Disease Resistance | 1 | 2020 | 34 | 0.040 |
Why?
| | Immediate-Early Proteins | 1 | 2020 | 49 | 0.040 |
Why?
| | Caenorhabditis elegans | 1 | 2024 | 306 | 0.040 |
Why?
| | DNA Repair | 1 | 2022 | 231 | 0.040 |
Why?
| | Protozoan Proteins | 1 | 2020 | 82 | 0.040 |
Why?
| | Escherichia coli Proteins | 1 | 2022 | 200 | 0.040 |
Why?
| | Antibody Affinity | 1 | 2020 | 60 | 0.040 |
Why?
| | Antibody Specificity | 1 | 2020 | 189 | 0.040 |
Why?
| | Middle Aged | 2 | 2021 | 33479 | 0.040 |
Why?
| | Carbamazepine | 1 | 2019 | 20 | 0.040 |
Why?
| | Nanoparticles | 1 | 2025 | 481 | 0.040 |
Why?
| | Genome | 1 | 2022 | 300 | 0.040 |
Why?
| | Guanosine Tetraphosphate | 1 | 2018 | 5 | 0.040 |
Why?
| | Viral Proteins | 1 | 2021 | 342 | 0.040 |
Why?
| | Staphylococcus aureus | 1 | 2003 | 450 | 0.040 |
Why?
| | Unfolded Protein Response | 1 | 2018 | 59 | 0.040 |
Why?
| | Embryo, Mammalian | 1 | 2019 | 232 | 0.040 |
Why?
| | Genes, Bacterial | 1 | 2018 | 164 | 0.040 |
Why?
| | Adult | 2 | 2021 | 37929 | 0.040 |
Why?
| | Salmonella | 1 | 2018 | 62 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2011 | 375 | 0.040 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2003 | 1242 | 0.040 |
Why?
| | Protein Denaturation | 1 | 2017 | 74 | 0.030 |
Why?
| | RNA, Bacterial | 1 | 2018 | 190 | 0.030 |
Why?
| | Apoptosis | 1 | 2006 | 2553 | 0.030 |
Why?
| | MafF Transcription Factor | 1 | 2017 | 1 | 0.030 |
Why?
| | Proteolysis | 1 | 2018 | 177 | 0.030 |
Why?
| | Proline | 1 | 2017 | 79 | 0.030 |
Why?
| | Hydrogen Peroxide | 1 | 2018 | 328 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2021 | 1389 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 660 | 0.030 |
Why?
| | Brain | 2 | 2021 | 2668 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2018 | 810 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2021 | 1483 | 0.030 |
Why?
| | Nuclear Proteins | 2 | 2017 | 712 | 0.030 |
Why?
| | Risk | 1 | 2019 | 912 | 0.030 |
Why?
| | Substrate Specificity | 2 | 2010 | 372 | 0.030 |
Why?
| | Genomics | 1 | 2022 | 795 | 0.030 |
Why?
| | Phytotherapy | 1 | 2017 | 83 | 0.030 |
Why?
| | Arginine | 1 | 2018 | 271 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2019 | 433 | 0.030 |
Why?
| | Baculoviridae | 1 | 2015 | 44 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1009 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2017 | 237 | 0.030 |
Why?
| | Bcl-2-Like Protein 11 | 2 | 2006 | 38 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2020 | 5757 | 0.030 |
Why?
| | Saliva | 1 | 2017 | 242 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2017 | 767 | 0.030 |
Why?
| | HIV Reverse Transcriptase | 1 | 2014 | 31 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2017 | 305 | 0.030 |
Why?
| | Apoptosis Regulatory Proteins | 2 | 2006 | 188 | 0.030 |
Why?
| | Male | 2 | 2021 | 67762 | 0.030 |
Why?
| | DNA Primers | 1 | 2014 | 515 | 0.030 |
Why?
| | Sodium | 1 | 2014 | 217 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2014 | 361 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 4030 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2018 | 1317 | 0.020 |
Why?
| | Lung | 2 | 2016 | 4060 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2014 | 730 | 0.020 |
Why?
| | Proto-Oncogene Proteins | 2 | 2006 | 648 | 0.020 |
Why?
| | Virus Replication | 1 | 2014 | 483 | 0.020 |
Why?
| | HLA Antigens | 1 | 2013 | 240 | 0.020 |
Why?
| | Epitope Mapping | 1 | 2011 | 62 | 0.020 |
Why?
| | Leukemia, Experimental | 1 | 2010 | 27 | 0.020 |
Why?
| | Rats | 1 | 2019 | 5647 | 0.020 |
Why?
| | Genes, MHC Class I | 1 | 2010 | 35 | 0.020 |
Why?
| | Binding, Competitive | 1 | 2010 | 202 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2010 | 86 | 0.020 |
Why?
| | Neurons | 1 | 2019 | 1590 | 0.020 |
Why?
| | RNA, Double-Stranded | 1 | 2010 | 57 | 0.020 |
Why?
| | Vaccines, Synthetic | 1 | 2010 | 126 | 0.020 |
Why?
| | DNA, Single-Stranded | 1 | 2010 | 118 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1916 | 0.020 |
Why?
| | Algorithms | 1 | 2017 | 1704 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2010 | 686 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3196 | 0.020 |
Why?
| | Germ-Line Mutation | 1 | 2009 | 172 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 399 | 0.020 |
Why?
| | Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 391 | 0.020 |
Why?
| | bcl-2 Homologous Antagonist-Killer Protein | 1 | 2006 | 15 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2010 | 728 | 0.020 |
Why?
| | Enterotoxins | 1 | 2006 | 88 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2006 | 155 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2006 | 99 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 2006 | 111 | 0.020 |
Why?
| | Immunotherapy | 1 | 2010 | 641 | 0.010 |
Why?
| | Point Mutation | 1 | 2006 | 235 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 945 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2011 | 2475 | 0.010 |
Why?
| | B-Cell Activation Factor Receptor | 1 | 2003 | 13 | 0.010 |
Why?
| | B-Cell Activating Factor | 1 | 2003 | 21 | 0.010 |
Why?
| | Neuropeptides | 1 | 2003 | 73 | 0.010 |
Why?
| | Solubility | 1 | 2003 | 245 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 187 | 0.010 |
Why?
| | DNA, Bacterial | 1 | 2003 | 337 | 0.010 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 385 | 0.010 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2003 | 328 | 0.010 |
Why?
|
|
Dai's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|